Views & Analysis How one pharma “family business” places patients first When people think about pharma, they often think about “big” pharma: large, faceless corporations.
News Boehringer forges $7bn alliance with China's SBP Group Boehringer Ingelheim is paying $358m upfront for options on up to six antibody-drug conjugates and T cell engagers from China's Sino Biopharma.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
